fMRI and IVCM Cornea Microscopy of CXL in Keratoconus

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age8-35
SponsorBoston Children's Hospital

About this trial

Evaluation of neuroplasticity of pain pathways and corneal afferent nerve regeneration following corneal crosslinking (CXL) in keratoconus patients using fMRI and corneal In Vivo Confocal Microscopy (IVCM).

Eligibility criteria

Qualifiers

Age 8-35 years

Clinical diagnosis of keratoconus and seeking CXL treatment

English speaking ability sufficient to comprehend consent with parental assistance

MRI compatible

Disqualifiers

Claustrophobic

Weight > 285 lbs (weight limit of the MRI table)

Magnetic implants or metal-containing tattoos on their chest or above

Pregnancy

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

60 Participants
are grouped into 2 trial groups

Sponsors and collaborators